Autoantibody to DNA binding protein B as a novel serologic marker in systemic sclerosis

Biochemical and Biophysical Research Communications

Volumn 299, Issue 4, 2002, Pages 549-554

  Jeoung, Doo Il ^a   Bong Lee, Eun ^a   Lee, Seongeun ^a   Lim, Yoon ^a   Lee, Dae Yeon ^a   Kim, Jongwan ^a   Kim, Hae Yeong ^b   Wook Song, Yeong ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Kyung Hee University   (South Korea)

Author keywords

Autoantibody; DNA binding protein B; SEREX; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; COMPLEMENTARY DNA; DNA BINDING PROTEIN; ISOPROTEIN; PHOSPHOGLYCERATE MUTASE; RECOMBINANT PROTEIN; RIBONUCLEOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; DERMATOMYOSITIS; DNA LIBRARY; FEMALE; GENE EXPRESSION; HEALTH STATUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; POLYMYOSITIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RHEUMATOID ARTHRITIS; SEROLOGY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CCAAT-ENHANCER-BINDING PROTEINS; DNA-BINDING PROTEINS; FEMALE; GENE LIBRARY; HUMANS; MALE; MIDDLE AGED; NFI TRANSCRIPTION FACTORS; SCLERODERMA, SYSTEMIC; SEROLOGIC TESTS; TRANSCRIPTION FACTORS; Y-BOX-BINDING PROTEIN 1;

EID: 0036926139     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02685-2     Document Type: Article

References (24)

1. F. Arnett, HLA and autoimmunity in scleroderma (systemic sclerosis), Intern. Rev. Immunol. 12 (1995) 107-128.
2. E.C. LeRoy, E.A. Smith, M.B. Kahaleh, M. Trojanowska, R.M. Silver, A strategy for determining the pathogenesis of systemic sclerosis: Is transforming growth factor β the answer? Arthritis Rheum. 32 (1989) 817-825.
3. A. Parodi, M. Drosera, L. Barbieri, A. Rebora, Scleroderma subsets are best detected by the simultaneous analysis of the autoantibody profile using commercial ELISA, Dermatology 204 (1) (2002) 29-32.
4. M. Kuwana, T.A. Medsger Jr., T.M. Wright, T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors, J. Clin. Invest. 96 (1995) 586.
5. X. Zhou, F.X. Tan, M. Xiong, et al., Systemic sclerosis (scleroderma): Specific autoantigen genes are overexpressed in scleroderma fibroblasts, J. Immunol. 167 (12) (2001) 7126-7133.
6. R. Schmitts, B. Kubuschok, S. Schuster, K.D. Preuss, M. Pfreundschuh, Analysis of the repertoire against autoantigens in patients with giant cell arteries and polymyalgia rheumatica, Clin. Exp. Immunol. 127 (2002) 379-385.
7. Y.T. Chen, A.O. Gure, S. Tsang, et al., Identification of multiple cancer/testis antigens by allogenic antibody screening of a melanoma cell line library, Proc. Natl. Acad. Sci. 95 (1998) 6919-6923.
8. F. Skoldberg, L. Ronnblom, M. Thornemo, A. Lindahl, P.I. Bird, F. Rorsman, O. Kampe, E. Landgren, Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus, Biochem. Biophys. Res. Commun. 29 (2002) 951-958.
9. Y. Lim, D.-Y. Lee, S. Lee, S.-Y. Park, J. Kim, B. Cho, H. Lee, H.-Y. Kim, E. Lee, Y.W. Song, D.-I. Jeoung, Identification of autoantibodies associated with systemic lupus erythematosus, Biochem. Biophys. Res. Commun. 295 (2002) 119-124.
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum. 23 (1980) 581-590.
11. Y. Tokano, M. Yasuma, S. Hrada, Y. Takasaki, H. Hashimoto, K. Okumura, S. Hirose, Clinical significance of IgG subclasses of anti-Sm and U1 ribonucleoprotein antibodies in patients with systemic lupus erythematosus and mixed connective tissue disease, J. Clin. Immunol. 11 (1991) 317-325.
12. S.D. Bliazarian, A.J. Taylor, D. Brezinski, M.C. Hochber, T. Guarnieri, T.T. Provost, High grade atrioventricular heart block in adult with systemic lupus erythematosus: The association of nuclear RNP (U1 RNP) antibodies, a case report, and review of the literature, Arthritis Rheum. 32 (9) (1989) 1170-1174.
13. O.I. Stenina, K.M. Shaneyfelt, P.E. DiCorleto, Thrombin induces the release of the Y-box protein dbpB from mRNA: A mechanism of transcriptional activation, Proc. Natl. Acad. Sci. 98 (13) (2001) 7277-7282.
14. J.T. Norman, G.E. Lindahl, K. Shakib, A. En-Nia, E. Yilmaz, P.R. Mertens, The Y-box binding protein YB-1 suppresses collagen α1(I) gene transcription via an evolutionarily conserved regulatory element in the proximal promoter, J. Biol. Chem. 276 (2001) 29880-29890.
15. E.E. Capowski, S. Esnault, S. Bhattacharya, J.S. Malter, Y-box binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA, J. Immunol. 167 (2001) 5970-5976.
16. D.R. Marenstein, M.T.A. Ocampo, M.K. Chan, A. Altamirano, A.K. Basus, R.J. Boorstein, R.P. Cunningham, G.W. Teebor, Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B), J. Biol. Chem. 276 (24) (2001) 21242-21249.
17. O.I. Stenina, E.J. Poptic, P.R. DiCorleto, Thrombin activates a Y-box-binding protein (DNA-binding protein B) in endothelial cells, J. Clin. Invest. 106 (4) (2000) 579-587.
18. A. Jelaska, M. Arakawa, G. Broketa, J.H. Korn, Heterogeneity in collagen synthesis in normal and systemic sclerosis skin fibroblasts: Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts, Arthritis Rheum. 39 (1996) 1338-1346.
19. T. Ohba, J.K. McDonald, R.M. Siler, C. Strange, E.C. Leroy, A. Ludwicka, Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor α-receptor, Am. J. Respir. Cell. Mol. Biol. 10 (4) (1994) 405-412.
20. H. Takemura, H. Suzuki, H. Fujisawa, et al., Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor, J. Rheumatol. 25 (8) (1998) 1534-1539.
21. X.Y. Zheng, J.Z. Zhang, P. Tu, S.Q. Ma, Expression of platelet-derived growth factor B-chain and platelet-derived growth factor β-receptor in fibroblasts of scleroderma, J. Dermatol. Sci. 18 (2) (1998) 90-97.
22. A. Ludwicka, T. Ohba, M. Trojanowska, A. Yamakage, C. Strange, E.A. Smith, E.C. Leroy, S. Sutherland, R.M. Silver, Elevated levels of platelet derived growth factor and transforming growth factor-β1 in bronchoalveolar lavage fluid from patients with scleroderma, J. Rheumatol. 22 (10) (1995) 1876-1883.
23. L. Klareskog, R. Gustafsson, A. Scheynius, R. Hallgren, Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis, Arthritis Rheum. 33 (10) (1990) 1534-1541.
24. J. Czuwara-Ladykowska, E.A. Gore, D.A. Shegogue, E.A. Smith, M. Trojanowska, Differential regulation of transforming growth factor-β receptors type I and II by platelet-derived growth factor in human dermal fibroblasts, Br. J. Dermatol. 145 (4) (2001) 569-575.